Abstract
Secretin was given intravenously to four normal men as a 150 U pharmacologic pulse. To an additional four men, during hyperglycemia, secretin was administered as a 5 U pulse with an infusion of 1.2 U per minute for 30 minutes, a rate shown to produce plasma secretin levels similar to those found after oral glucose load. Although insulin increased an average of 7 and 12 fold during the respective infusions, secretin did not significantly alter glucagon levels. These data suggest that, in humans, secretin influences glucose utilization by enhancing insulin release without producing a concomitant change in glucagon.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
